Halfan Related Published Studies
Well-designed clinical trials related to Halfan (Halofantrine)
Effects of prior administration of amodiaquine on the disposition of halofantrine in healthy volunteers. [2007.04]
Well-designed clinical trials possibly related to Halfan (Halofantrine)
Artemether-lumefantrine (four-dose regimen) for treating uncomplicated falciparum malaria. [2006.04.19]
Atovaquone-proguanil for treating uncomplicated malaria. [2005.10.19]
Other research related to Halfan (Halofantrine)
Changes in antioxidant status and biochemical indices after acute administration of artemether, artemether-lumefantrine and halofantrine in rats. [2008.04]
Effect of kolanut on the pharmacokinetics of the antimalarial drug halofantrine. [2008.01]
Effect of kolanut on the pharmacokinetics of the antimalarial drug halofantrine. [2007.10.20]
Cardiotoxicity reduction induced by halofantrine entrapped in nanocapsule devices. [2007.03.13]
Surface-modified and conventional nanocapsules as novel formulations for parenteral delivery of halofantrine. [2006.09]
Decreasing pfmdr1 copy number in plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin. [2006.08.15]
Efficacy and safety of halofantrine in Pakistani children and adults with malaria caused by P. falciparum and P. vivax. [2006.07]
[Mefloquine versus halofantrine in children suffering from acute uncomplicated falciparum malaria] [2005.04]
Other possibly related research studies
An examination of the interplay between enterocyte-based metabolism and lymphatic drug transport in the rat. [2006.05]
The lymph lipid precursor pool is a key determinant of intestinal lymphatic drug transport. [2006.02]
Antimalarial prescribing practices: a challenge to malaria control in Ghana. [2005.09]
Antimalarial drugs: QT prolongation and cardiac arrhythmias. [2005.05]
[Effects of antimalarial drugs and cardiomyocytes. Pathogenic approach and new therapeutic recommendations] [2006.02]
[A mild blackwater fever] [2006.06]
Role of US military research programs in the development of US Food and Drug Administration--approved antimalarial drugs. [2006.07.01]
Treatment of imported malaria in adults: a multicentre study in France. [2005.10]
Overestimating resistance in field testing of malaria parasites: simple methods for estimating high EC50 values using a Bayesian approach. [2007.01.17]
TDR collaboration with the pharmaceutical industry. [2006.12]
WITHDRAWN: Artemether-lumefantrine for treating uncomplicated falciparum malaria. [2007.07.18]
Cardiotoxicity of antimalarial drugs. [2007.08]
The in-vitro susceptibilities of Ghanaian Plasmodium falciparum to antimalarial drugs. [2007.07]
[Tolerance and efficacy of mefloquine as the first line treatment of uncomplicated P. falciparum malaria in children] [2008.02]
In vitro monitoring of Plasmodium falciparum drug resistance in French Guiana: a synopsis of continuous assessment from 1994 to 2005. [2008.01]
|
